| abstract |
The present invention relates to a Xage-1d marker for diagnosing lung cancer and to a diagnostic kit using same. In more detail, after confirming that Xage-1d exists in a culture fluid of a lung cancer cell line, it is verified that the amount of the Xage-1d in the serum of an actual lung cancer patient is higher than that of a normal person, and that the sensitivity is excellent, thereby confirming that the Xage-1d can be used as a lung cancer diagnosis marker and can be utilized in a diagnostic kit for lung cancer. |